Question 1

What was Sanofi Consumer Healthcare India's net profit in Q2 FY27?

Accepted Answer

Consolidated net profit was ₹76.6 crore, up 21.8% from ₹62.9 crore in Q2 FY26 and up 11.3% from ₹68.8 crore in Q1 FY27.

Question 2

What was Sanofi Consumer Healthcare India's revenue in Q2 FY27?

Accepted Answer

Revenue from operations was ₹263 crore, up 12.5% year on year and up 11.6% from the previous quarter.

Question 3

What was Sanofi Consumer Healthcare India's net profit in the year to December 2025?

Accepted Answer

Consolidated net profit was ₹240 crore in the year to December 2025 (January 2024–December 2025), up 32.7% from ₹181 crore in the year to December 2024.

Question 4

How were Sanofi Consumer Healthcare India's Q2 FY27 results?

Accepted Answer

Both grew from a year earlier: net profit was up 21.8% at ₹76.6 crore and revenue was up 12.5% at ₹263 crore. The operating margin was 37.5%, up 2.5 percentage points from 34.9% a year earlier. Against Q1 FY27, net profit was up 11.3% and revenue up 11.6%.

Question 5

What was Sanofi Consumer Healthcare India's operating margin in Q2 FY27?

Accepted Answer

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹98.6 crore, a margin of 37.5%, against 36.5% in Q1 FY27 and 34.9% in Q2 FY26. EBITDA was ₹102 crore, 38.7% of revenue.

Question 6

What is Sanofi Consumer Healthcare India's net profit margin?

Accepted Answer

Sanofi Consumer Healthcare India's net profit margin was 29.1% in Q2 FY27 (net profit as a share of revenue from operations), against 26.9% in Q2 FY26 (up 2.2 percentage points). For the year to December 2025 as a whole it was 27.3%.

Question 7

What was Sanofi Consumer Healthcare India's EPS in Q2 FY27?

Accepted Answer

Basic earnings per share were ₹33.26, against ₹27.31 in Q2 FY26.

Question 8

What was Sanofi Consumer Healthcare India's revenue in the year to December 2025?

Accepted Answer

Revenue from operations was ₹878 crore in the year to December 2025 (January 2024–December 2025), up 21.2% from ₹725 crore in the year to December 2024.

Question 9

When did Sanofi Consumer Healthcare India announce its Q2 FY27 results?

Accepted Answer

On Wednesday, 28 October 2026 at 6:46 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 12 November 2025.

Question 10

What was Sanofi Consumer Healthcare India's net profit in the first half of FY27?

Accepted Answer

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹145 crore, up 17.6% from ₹124 crore in the same months a year earlier. Revenue from operations was ₹499 crore, up 9.7%.

Question 11

How has Sanofi Consumer Healthcare India's profit changed over the last four quarters?

Accepted Answer

Net profit by quarter: ₹66.5 crore in Q3 FY26, ₹67.8 crore in Q4 FY26, ₹68.8 crore in Q1 FY27 and ₹76.6 crore in Q2 FY27. That is ₹280 crore over the four quarters, up 28.4% from ₹218 crore in the four quarters before. Revenue from operations: ₹251 crore, ₹229 crore, ₹236 crore and ₹263 crore.

Question 12

When will Sanofi Consumer Healthcare India announce its Q3 FY27 results?

Accepted Answer

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Question 13

Where do these Sanofi Consumer Healthcare India figures come from?

Accepted Answer

From Sanofi Consumer Healthcare India's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 28 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Expenses
	263	236	229	251	234	221	173	171	160	164
	4.4	6.3	5.6	4.6	3.0	5.6	5.2	5.0	4.2	0.8
	268	242	235	256	237	227	178	176	164	165
	40.7	47.5	40.2	49.9	36.5	55.4	18.9	14.8	14.1	31.7
	11.6	16.0	18.1	6.1	26.0	4.6	33.5	18.4	14.4	0.0
	12.1	−7.2	−2.1	12.3	−0.7	1.2	−13.6	8.7	10.2	13.8
	30.7	31.3	33.1	35.5	31.7	32.0	29.6	27.6	27.4	24.8
	0.3	0.4	0.5	0.5	0.6	0.5	0.4	0.4	3.4	0.1
	3.1	3.3	3.2	3.4	3.3	3.0	2.0	1.0	1.5	1.1
	66.3	58.8	51.1	57.4	55.4	57.5	40.2	39.1	30.7	30.5
	165	150	144	165	153	154	111	110	102	102
	102	89.3	88.8	89.8	85.0	70.2	64.0	62.1	63.1	63.6
	98.6	86.0	85.6	86.4	81.7	67.2	62.0	61.1	61.6	62.5
Profit
	103	91.9	90.7	90.5	84.1	72.3	66.8	65.7	62.4	63.2
	0.0	0.0	0.0	0.0	0.0	6.6	0.0	−2.9	−1.2	−24.3
	103	91.9	90.7	90.5	84.1	78.9	66.8	62.8	61.2	38.9
	26.6	23.4	24.1	24.1	22.5	18.4	17.0	17.6	16.9	13.0
	−0.5	−0.3	−1.2	−0.1	−1.3	−0.2	−0.2	0.9	−0.7	−3.1
	26.1	23.1	22.9	24.0	21.2	18.2	16.8	18.5	16.2	9.9
	76.6	68.8	67.8	66.5	62.9	60.7	50.0	44.3	45.0	29.0
	76.6	68.8	67.8	66.5	62.9	60.7	50.0	44.3	45.0	29.0
	−0.8	0.0	0.0	−1.4	0.0	0.0	0.0	−1.4	0.0	0.0
	75.8	68.8	67.8	65.1	62.9	60.7	50.0	42.9	45.0	29.0
Per share
	₹33.26	₹29.87	₹29.44	₹28.87	₹27.31	₹26.36	₹21.69	₹19.25	₹19.54	₹12.58
	₹33.26	₹29.87	₹29.44	₹28.87	₹27.31	₹26.36	₹0.00	₹0.00	₹19.54	₹12.58
Other comprehensive income — detail
	−0.8	—	0.0	−1.4	—	—	0.0	—	—	—
	−1.1	—	—	−1.9	—	—	—	−1.9	—	—
	−0.3	—	0.0	−0.5	—	—	0.0	—	—	—
	—	—	—	—	—	—	—	−0.5	—	—
	—	—	—	—	—	—	—	0.0	45.0	0.0
Per share — as-filed variants
	₹33.26	₹29.87	₹29.44	₹28.87	₹27.31	₹26.36	₹21.69	₹19.25	₹19.54	₹12.58
	₹33.26	₹29.87	₹29.44	₹28.87	₹27.31	₹26.36	₹0.00	₹0.00	₹19.54	₹12.58
Regulatory disclosures — filed alongside, not part of the P&L
	—	147	—	147	—	212	—	—	—	—
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	199	179	173	183	172	160	134	129	121	119
	75.5%	76.1%	75.5%	72.8%	73.6%	72.3%	77.5%	75.5%	75.8%	72.3%
Adjusted (ex-exceptional items) — derived
	103	91.9	90.7	90.5	84.1	72.3	66.8	65.7	62.4	63.2
	0.0	0.0	0.0	0.0	0.0	6.6	0.0	−2.9	−1.2	−24.3
	76.6	68.8	67.8	66.5	62.9	55.6	50.0	46.3	45.9	47.1
	₹33.26	₹29.87	₹29.44	₹28.87	₹27.31	₹24.15	₹21.69	₹20.14	₹19.92	₹20.44

In ₹ Crore except Per Share 3 Months Ending	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	164.4	159.9	170.7	172.6	220.9	233.9	251.0	229.2	235.7	263.1
Other Income	0.8	4.2	5.0	5.2	5.6	3.0	4.6	5.6	6.3	4.4
Total Income	165.2	164.1	175.7	177.8	226.5	236.9	255.6	234.8	242.0	267.5
Expenses
+ Cost of Materials Consumed	31.7	14.1	14.8	18.9	55.4	36.5	49.9	40.2	47.5	40.7
+ Purchases of Stock-in-Trade	0.0	14.4	18.4	33.5	4.6	26.0	6.1	18.1	16.0	11.6
+ Changes in Inventories	13.8	10.2	8.7	-13.6	1.2	-0.7	12.3	-2.1	-7.2	12.1
+ Employee Benefit Expense	24.8	27.4	27.6	29.6	32.0	31.7	35.5	33.1	31.3	30.7
+ Finance Costs	0.1	3.4	0.4	0.4	0.5	0.6	0.5	0.5	0.4	0.3
+ Depreciation & Amortisation	1.1	1.5	1.0	2.0	3.0	3.3	3.4	3.2	3.3	3.1
+ Other Expenses	30.5	30.7	39.1	40.2	57.5	55.4	57.4	51.1	58.8	66.3
Total Expenses	102.0	101.7	110.0	111.0	154.2	152.8	165.1	144.1	150.1	164.8
EBITDA	63.6	63.1	62.1	64.0	70.2	85.0	89.8	88.8	89.3	101.7
EBIT	62.5	61.6	61.1	62.0	67.2	81.7	86.4	85.6	86.0	98.6
Profit
PBT before Exceptional Items	63.2	62.4	65.7	66.8	72.3	84.1	90.5	90.7	91.9	102.7
+ Exceptional Items	-24.3	-1.2	-2.9	0.0	6.6	0.0	0.0	0.0	0.0	0.0
Pretax Income	38.9	61.2	62.8	66.8	78.9	84.1	90.5	90.7	91.9	102.7
+ Current Tax	13.0	16.9	17.6	17.0	18.4	22.5	24.1	24.1	23.4	26.6
+ Deferred Tax	-3.1	-0.7	0.9	-0.2	-0.2	-1.3	-0.1	-1.2	-0.3	-0.5
Tax Expense	9.9	16.2	18.5	16.8	18.2	21.2	24.0	22.9	23.1	26.1
Net Income	29.0	45.0	44.3	50.0	60.7	62.9	66.5	67.8	68.8	76.6
+ Net Income — Continuing Ops	29.0	45.0	44.3	50.0	60.7	62.9	66.5	67.8	68.8	76.6
+ Other Comprehensive Income	0.0	0.0	-1.4	0.0	0.0	0.0	-1.4	0.0	0.0	-0.8
Total Comprehensive Income	29.0	45.0	42.9	50.0	60.7	62.9	65.1	67.8	68.8	75.8
Per Share
Basic EPS	12.58	19.54	19.25	21.69	26.36	27.31	28.87	29.44	29.87	33.26
Diluted EPS	12.58	19.54	0.00	0.00	26.36	27.31	28.87	29.44	29.87	33.26
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	0.0	—	—	-1.4	0.0	—	-0.8
+ Items NOT to be Reclassified to P&L	—	—	-1.9	—	—	—	-1.9	—	—	-1.1
+ Tax on Items NOT to be Reclassified	—	—	—	0.0	—	—	-0.5	0.0	—	-0.3
+ Tax on Items NOT to be Reclassified — alt tag	—	—	-0.5	—	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	0.0	45.0	0.0	—	—	—	—	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	12.58	19.54	19.25	21.69	26.36	27.31	28.87	29.44	29.87	33.26
Diluted EPS — Continuing Operations	12.58	19.54	0.00	0.00	26.36	27.31	28.87	29.44	29.87	33.26
Regulatory Disclosures — filed alongside, not part of the P&L
Related-party Transactions — During the Period	—	—	—	—	212.0	—	147.1	—	147.2	—
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	118.9	121.2	128.8	133.8	159.7	172.1	182.7	173.0	179.4	198.7
Gross Margin %	72.32	75.80	75.45	77.52	72.30	73.58	72.79	75.48	76.11	75.52
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	63.2	62.4	65.7	66.8	72.3	84.1	90.5	90.7	91.9	102.7
− Exceptional Items (reconciliation)	-24.3	-1.2	-2.9	0.0	6.6	0.0	0.0	0.0	0.0	0.0
Net Income Adj (tax-effected)	47.1	45.9	46.3	50.0	55.6	62.9	66.5	67.8	68.8	76.6
EPS Adj	20.44	19.92	20.14	21.69	24.15	27.31	28.87	29.44	29.87	33.26
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	—	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	23.0	23.0	23.0	23.0	23.0	23.0	23.0	23.0	23.0	23.0

Sanofi Consumer Healthcare India quarterly results

Every quarter

Sanofi Consumer Healthcare India Limited

Sanofi Consumer Healthcare India Q2 FY27 results (July–September 2026)

Q2 FY27 at a glance · consolidated

Questions